Grace Therapeutics, Inc. (ACST)
2.12
+0.02
(+0.95%)
USD |
NASDAQ |
Sep 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 34.50M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -34.57% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 0.7156 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Grace Therapeutics, Inc. engages in the development and commercialization of drug candidates for rare and orphan diseases. It focuses on utilizing proprietary technologies to improve the performance of currently marketed drugs. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ. |
| URL | http://www.gracetx.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | |
| Industry | |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Jun. 20, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Grace Therapeutics, Inc. engages in the development and commercialization of drug candidates for rare and orphan diseases. It focuses on utilizing proprietary technologies to improve the performance of currently marketed drugs. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ. |
| URL | http://www.gracetx.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | |
| Industry | |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Jun. 20, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |